Patents by Inventor Thomas A. Williamson
Thomas A. Williamson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11969306Abstract: Oral hygiene monitoring system is disclosed to track motion and orientation of an oral hygiene device. The control system may process data output from a motion sensor to determine position and orientation of an oral hygiene device with respect to a user's mouth. In some examples, the system may use machine learning techniques to identify position and orientation, brush stroke type, and other specific actions.Type: GrantFiled: June 16, 2023Date of Patent: April 30, 2024Assignee: KOLIBREE SASInventors: Thomas Serval, Yann Nicolas, LĂ©onie Williamson
-
Patent number: 11709687Abstract: A method and system for improving accessibility of advanced coding to individuals with limited dexterity using a personalized screen touch option as replacement of standard typing, to the user's functional mobility ability. The system and method involve a touchscreen coding platform and a personalized screen touch option corresponding to the user's functional mobility activity, which allows the user to write with their prefer code language at a professional level. All actions on the coding platform may be performed with finger taps allowing individuals with limited dexterity to perform complex coding.Type: GrantFiled: April 3, 2021Date of Patent: July 25, 2023Assignee: BeEnabled, L.L.C.Inventors: Jennifer Grace Schlegel, Ryan Thomas Williamson
-
Patent number: 11542374Abstract: The invention is directed to a composite material comprising a biofabricated material and a secondary component. The secondary component may be a porous material, such as a sheet of paper, cellulose, or fabric that has been coated or otherwise contacted with the biofabricated material. The biofabricated material comprises a uniform network of crosslinked collagen fibrils and provides strength, elasticity and an aesthetic appearance to the composite material.Type: GrantFiled: February 15, 2017Date of Patent: January 3, 2023Assignee: MODERN MEADOW, INC.Inventors: Brendan Patrick Purcell, David Thomas Williamson, Suzanne Lee, Amy Congdon
-
Patent number: 11530304Abstract: A biofabricated material comprising a network of crosslinked collagen fibrils produced from recombinant collagen that contains substantially no 3-hydroxyproline residues is disclosed. This material is composed of collagen which is also a major component of natural leather and is produced by a process of fibrillation of collagen molecules into fibrils, crosslinking the fibrils and lubricating the crosslinked fibrils. Unlike natural leathers, this biofabricated material exhibits non-anisotropic (not directionally dependent) physical properties, for example, a sheet of biofabricated material can have substantially the same elasticity or tensile strength when stretched or stressed in different directions. Unlike natural leather, it has a uniform texture that facilitates uniform uptake of dyes and coatings. Aesthetically, it produces a uniform and consistent grain for ease of manufacturability.Type: GrantFiled: February 15, 2017Date of Patent: December 20, 2022Assignee: MODERN MEADOW, INC.Inventors: Brendan Patrick Purcell, David Thomas Williamson, Lixin Dai, Darryl Miles Cassingham, Stephen M. Spinella, Katherine Amy Congdon
-
Patent number: 11525042Abstract: The invention is directed to a composite material comprising a biofabricated material and a secondary component. The secondary component may be a porous material, such as a sheet of paper, cellulose, or fabric that has been coated or otherwise contacted with the biofabricated material. The biofabricated material comprises a uniform network of crosslinked collagen fibrilsand provides strength, elasticity and an aesthetic appearance to the composite material.Type: GrantFiled: February 15, 2017Date of Patent: December 13, 2022Assignee: MODERN MEADOW, INC.Inventors: Brendan Patrick Purcell, David Thomas Williamson, Suzanne Lee, Amy Congdon
-
Patent number: 11286354Abstract: Described herein is a method for producing a biofabricated material from collagen or collagen-like proteins. The collagen or collagen-like proteins are isolated from animal sources or produced by recombinant DNA techniques or by chemical synthesis. The collagen or collagen-like proteins are fibrillated, crosslinked, dehydrated and lubricated thus forming the biofabricated material having a substantially uniform network of collagen fibrils.Type: GrantFiled: February 15, 2017Date of Patent: March 29, 2022Assignee: MODERN MEADOW, INC.Inventors: Brendan Patrick Purcell, David Thomas Williamson, Francoise Suzanne Marga, Susan J. Schofer, Darryl Miles Cassingham
-
Publication number: 20210311750Abstract: A method and system for improving accessibility of advanced coding to individuals with limited dexterity using a personalized screen touch option as replacement of standard typing. to the user's functional mobility ability. The system and method involve a touch-screen coding platform and a personalized screen touch option corresponding to the user's functional mobility activity, which allows the user to write with their prefer code language at a professional level. All actions on the coding platform may be performed with finger taps allowing individuals with limited dexterity to perform complex coding.Type: ApplicationFiled: April 3, 2021Publication date: October 7, 2021Applicant: BeEnabled, L.L.C.Inventors: Jennifer Grace SCHLEGEL, Ryan Thomas WILLIAMSON
-
Patent number: 11028146Abstract: This invention relates to genetically engineered strains of yeast and methods for producing recombinant protein (e.g., collagen). Recombinant protein of the present invention is used to produce biofabricated leather or a material having leather-like properties containing recombinant or engineered collagen. The yeast strains are engineered to produce ascorbate and/or increased production of ? ketoglutarate.Type: GrantFiled: September 7, 2018Date of Patent: June 8, 2021Assignee: MODERN MEADOW, INC.Inventors: Lixin Dai, Kristin Ruebling-Jass, David Thomas Williamson
-
Patent number: 11001679Abstract: A biofabricated material containing a network of crosslinked collagen fibrils is disclosed. This material is composed of collagen which is also a major component of natural leather and is produced by a process of fibrillation of collagen molecules into fibrils, crosslinking the fibrils and lubricating the crosslinked fibrils. Unlike natural leathers, this biofabricated material exhibits non-anisotropic (not directionally dependent) physical properties, for example, a sheet of biofabricated material can have substantially the same elasticity or tensile strength when stretched or stressed in different directions. Unlike natural leather, it has a uniform texture that facilitates uniform uptake of dyes and coatings. Aesthetically, it produces a uniform and consistent grain for ease of manufacturability. It can have substantially identical grain, texture and other aesthetic properties on both sides distinct from natural leather where the grain increases from one side (e.g.Type: GrantFiled: March 19, 2019Date of Patent: May 11, 2021Assignee: Modern Meadow, Inc.Inventors: Brendan Patrick Purcell, David Thomas Williamson, Lixin Dai, Darryl Miles Cassingham, Stephen M. Spinella
-
Publication number: 20200207932Abstract: The invention is directed to a method for producing a composite material comprising a biofabricated material and a secondary component. The secondary component may be a porous material, such as a sheet of paper, cellulose, or fabric that has been coated or otherwise contacted with the biofabricated material. The biofabricated material comprises a uniform network of crosslinked collagen fibrils and provides strength, elasticity and an aesthetic appearance to the composite material.Type: ApplicationFiled: November 4, 2019Publication date: July 2, 2020Applicant: Modern Meadow, Inc.Inventors: Brendan Patrick PURCELL, David Thomas WILLIAMSON, Suzanne LEE, Amy CONGDON
-
Patent number: 10519285Abstract: The invention is directed to a method for producing a composite material comprising a biofabricated material and a secondary component. The secondary component may be a porous material, such as a sheet of paper, cellulose, or fabric that has been coated or otherwise contacted with the biofabricated material. The biofabricated material comprises a uniform network of crosslinked collagen fibrils and provides strength, elasticity and an aesthetic appearance to the composite material.Type: GrantFiled: February 15, 2017Date of Patent: December 31, 2019Assignee: Modern Meadow, Inc.Inventors: Brendan Patrick Purcell, David Thomas Williamson, Suzanne Lee, Amy Congdon
-
Patent number: 10370505Abstract: The invention is directed to a composite material comprising a biofabricated material and a secondary component. The secondary component may be a porous material, such as a sheet of paper, cellulose, or fabric that has been coated or otherwise contacted with the biofabricated material. The biofabricated material comprises a uniform network of crosslinked collagen fibrils and provides strength, elasticity and an aesthetic appearance to the composite material.Type: GrantFiled: February 15, 2017Date of Patent: August 6, 2019Assignee: MODERN MEADOW, INC.Inventors: Brendan Patrick Purcell, David Thomas Williamson, Suzanne Lee, Amy Congdon
-
Patent number: 10370504Abstract: Described herein is a method for producing a biofabricated material from collagen or collagen-like proteins which are recombinantly produced and which contain substantially no 3-hydroxyproline. The collagen or collagen-like proteins are isolated from animal sources, or produced by recombinant DNA techniques or by chemical synthesis. The collagen or collagen-like proteins are fibrillated, crosslinked, dehydrated and lubricated thus forming the biofabricated material having a substantially uniform network of collagen fibrils.Type: GrantFiled: February 15, 2017Date of Patent: August 6, 2019Assignee: MODERN MEADOW, INC.Inventors: Brendan Patrick Purcell, David Thomas Williamson, Francoise Suzanne Marga, Susan J. Schofer, Darryl Miles Cassingham, Stephen M. Spinella, Amy Congdon
-
Publication number: 20190203000Abstract: A biofabricated material containing a network of crosslinked collagen fibrils is disclosed. This material is composed of collagen which is also a major component of natural leather and is produced by a process of fibrillation of collagen molecules into fibrils, crosslinking the fibrils and lubricating the crosslinked fibrils. Unlike natural leathers, this biofabricated material exhibits non-anisotropic (not directionally dependent) physical properties, for example, a sheet of biofabricated material can have substantially the same elasticity or tensile strength when stretched or stressed in different directions. Unlike natural leather, it has a uniform texture that facilitates uniform uptake of dyes and coatings. Aesthetically, it produces a uniform and consistent grain for ease of manufacturability. It can have substantially identical grain, texture and other aesthetic properties on both sides distinct from natural leather where the grain increases from one side (e.g.Type: ApplicationFiled: March 19, 2019Publication date: July 4, 2019Applicant: MODERN MEADOW, INC.Inventors: Brendan Patrick PURCELL, David Thomas WILLIAMSON, Lixin DAI, Darryl Miles CASSINGHAM, Stephen M. SPINELLA
-
Patent number: 10301440Abstract: A biofabricated material containing a network of crosslinked collagen fibrils is disclosed. This material is composed of collagen which is also a major component of natural leather and is produced by a process of fibrillation of collagen molecules into fibrils, crosslinking the fibrils and lubricating the crosslinked fibrils. Unlike natural leathers, this biofabricated material exhibits non-anisotropic (not directionally dependent) physical properties, for example, a sheet of biofabricated material can have substantially the same elasticity or tensile strength when stretched or stressed in different directions. Unlike natural leather, it has a uniform texture that facilitates uniform uptake of dyes and coatings. Aesthetically, it produces a uniform and consistent grain for ease of manufacturability. It can have substantially identical grain, texture and other aesthetic properties on both sides distinct from natural leather where the grain increases from one side (e.g.Type: GrantFiled: February 15, 2017Date of Patent: May 28, 2019Assignee: MODERN MEADOW, INC.Inventors: Brendan Patrick Purcell, David Thomas Williamson, Lixin Dai, Darryl Miles Cassingham, Stephen M. Spinella
-
Publication number: 20190093116Abstract: This invention relates to genetically engineered strains of yeast and methods, for producing recombinant protein (e.g., collagen). Recombinant protein of the present invention is used to produce biofabricated leather or a material having leather-like properties containing recombinant or engineered collagen. The yeast strains are engineered to produce ascorbate and/or increased production of ? ketoglutarate.Type: ApplicationFiled: September 7, 2018Publication date: March 28, 2019Applicant: MODERN MEADOW, INC.Inventors: Lixin Dai, Kristin Ruebling-Jass, David Thomas Williamson
-
Publication number: 20170233945Abstract: The invention is directed to a method for producing a composite material comprising a biofabricated material and a secondary component. The secondary component may be a porous material, such as a sheet of paper, cellulose, or fabric that has been coated or otherwise contacted with the biofabricated material. The biofabricated material comprises a uniform network of crosslinked collagen fibrils and provides strength, elasticity and an aesthetic appearance to the composite material.Type: ApplicationFiled: February 15, 2017Publication date: August 17, 2017Applicant: MODERN MEADOW, INC.Inventors: Brendan Patrick PURCELL, David Thomas WILLIAMSON, Suzanne LEE, Amy CONGDON
-
Publication number: 20170233944Abstract: A biofabricated material comprising a network of crosslinked collagen fibrils produced from recombinant collagen that contains substantially no 3-hydroxyproline residues is disclosed. This material is composed of collagen which is also a major component of natural leather and is produced by a process of fibrillation of collagen molecules into fibrils, crosslinking the fibrils and lubricating the crosslinked fibrils. Unlike natural leathers, this biofabricated material exhibits non-anisotropic (not directionally dependent) physical properties, for example, a sheet of biofabricated material can have substantially the same elasticity or tensile strength when stretched or stressed in different directions. Unlike natural leather, it has a uniform texture that facilitates uniform uptake of dyes and coatings. Aesthetically, it produces a uniform and consistent grain for ease of manufacturability.Type: ApplicationFiled: February 15, 2017Publication date: August 17, 2017Applicant: MODERN MEADOW, INC.Inventors: Brendan Patrick PURCELL, David Thomas WILLIAMSON, Lixin DAI, Darryl Miles CASSINGHAM, Stephen M. SPINELLA, Amy CONGDON
-
Publication number: 20170233838Abstract: A biofabricated material containing a network of crosslinked collagen fibrils is disclosed. This material is composed of collagen which is also a major component of natural leather and is produced by a process of fibrillation of collagen molecules into fibrils, crosslinking the fibrils and lubricating the crosslinked fibrils. Unlike natural leathers, this biofabricated material exhibits non-anisotropic (not directionally dependent) physical properties, for example, a sheet of biofabricated material can have substantially the same elasticity or tensile strength when stretched or stressed in different directions. Unlike natural leather, it has a uniform texture that facilitates uniform uptake of dyes and coatings. Aesthetically, it produces a uniform and consistent grain for ease of manufacturability. It can have substantially identical grain, texture and other aesthetic properties on both sides distinct from natural leather where the grain increases from one side (e.g.Type: ApplicationFiled: February 15, 2017Publication date: August 17, 2017Applicant: MODERN MEADOW, INC.Inventors: Brendan Patrick PURCELL, David Thomas WILLIAMSON, Lixin DAI, Darryl Miles CASSINGHAM, Stephen M. SPINELLA
-
Publication number: 20170233834Abstract: Described herein is a method for producing a biofabricated material from collagen or collagen-like proteins which are recombinantly produced and which contain substantially no 3-hydroxyproline. The collagen or collagen-like proteins are isolated from animal sources, or produced by recombinant DNA techniques or by chemical synthesis. The collagen or collagen-like proteins are fibrillated, crosslinked, dehydrated and lubricated thus forming the biofabricated material having a substantially uniform network of collagen fibrils.Type: ApplicationFiled: February 15, 2017Publication date: August 17, 2017Applicant: MODERN MEADOW, INCInventors: Brendan Patrick PURCELL, David Thomas Williamson, Francoise Suzanne Marga, Susan J. Schofer, Darryl Miles Cassingham, Stephen M. Spinella, Amy Congdon